By Elaine Donnelly
Extending sexual misconduct to combat units
Independent voices from the TWT Communities
Breast cancer patients taking the drug tamoxifen can cut their chances of having the disease come back or kill them if they stay on the pills for 10 years instead of five years as doctors recommend now, a major study finds.
Breast cancer patients taking the drug tamoxifen can cut their chances of having the disease come back or kill them if they stay on the pills for 10 years instead of five years as doctors recommend now, a major study finds.
Breast cancer experts are cheering what could be some of the biggest advances in more than a decade: two new medicines that significantly delay the time until women with very advanced cases get worse.
Remember the uproar last year when a government task force said most women don't need annual mammograms? It turns out that only half of women over 40 had been getting them that often to start with, even when they have insurance that covers screening.
"The result of this trial will have a major, immediate impact on premenopausal women," Ravdin said.
"The result of this trial will have a major, immediate impact on premenopausal women," Ravdin said.
